hit counter

Phentermine Side Effects & Adverse Reactions (List)

Phentermine is a natural monoamine alkaloid derivative that was initially approved by the United States FDA in 1959 as an anorectic (appetite suppressant) for the treatment of obesity.  It was popularized throughout the early 1970s under the brand name medication “Fastin,” marketed by King Pharmaceuticals.  In the late 1990s phentermine was discontinued from pharmaceutical circulation, …

Read more

Minocycline For Depression: Antibiotics As Antidepressants?

Minocycline is a broad-spectrum antibiotic of the tetracycline classification, indicating that its chemical structure consists of 4 hydrocarbon rings.  The fact that minocycline has a broad-spectrum mechanism indicates that it targets a wide-range of pathogenic (Gram-positive and Gram-negative) bacteria.  In fact, when compared to other tetracycline drugs, minocycline is regarded as having the “broadest spectrum” …

Read more

Armour Thyroid Side Effects & Adverse Reactions (List)

Armour Thyroid is a porcine-derived thyroid extract manufactured by Actavis Inc. (formerly by Forest Laboratories, Inc.) for the treatment of hypothyroidism.  Unlike synthetically engineered thyroid medications (e.g. levothyroxine), Armour Thyroid is completely natural, and as a result, is thought (by some users and professionals) to be safer and more biologically compatible with humans.  Additionally, many …

Read more

Noopept Side Effects & Adverse Reactions (List)

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) is a synthetic peptide manufactured in Russia by JSC LEKKO Pharmaceuticals.  Chemically, noopept is a hydrophilic proline with a dipeptide structure consisting of a phenylacetyl subunit bound to a small peptide chain of proline and glycine.  Although it isn’t technically classified as a “racetam” (due to its lacking of a 2-oxo-pyrrolidine …

Read more

Transcranial Magnetic Stimulation (TMS) For Depression: An Effective Treatment?

According to the World Health Organization (WHO), depression is projected to become the number one global disease burden by 2030.  Present-day statistics suggest that depression affects over 350 million people worldwide.  Among those who are depressed, seeking professional psychiatric treatment is often helpful. An estimated 66% of all individuals who seek treatment are able to …

Read more